ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease

ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, contract research, and manufacturing, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…










